The Impact of AI-Enhanced Clinical Trials on Patient Experiences - with Melissa Easy and Tim Riely of IQVIA

episode

The AI in Business Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Ireland collapse in Kosovo as Israel game looms 13 min · 25 Sep 2026 · Today with David McCullagh

The Week: Trump vs the Press, Meta’s AI Win, and the Turning Political Tide 22 min · 25 Sep 2026 · The Prof G Pod with Scott Galloway

Armchair Anonymous: Bad Customer 54 min · 25 Sep 2026 · Armchair Expert with Dax Shepard

The Parts We Can't Erase 45 min · 25 Sep 2026 · Untraditionally Lala

Headlines: Car crash kills junior police officer 4 min · 25 Sep 2026 · The Daily Aus

Day 268: Rebuilding the Temple (2026) 29 min · 25 Sep 2026 · The Bible in a Year (with Fr. Mike Schmitz)

Report any issue

Source

Recorded05 Jul 2023

Publishertechemergence.libsyn.com ↗

Handlerec:6021111

Show notes

Today's guests are Melissa Easy, Vice President and General Manager of Clinical Technologies at IQVIA, and Tim Riely, Vice President of Clinical Data Analytics at IQVIA. They join Emerj Senior Editor Matthew DeMello on the program to talk about the current state of AI in life sciences and clinical trials. Throughout the episode, Melissa and Tim underscore the extent that clinical trials are changing thanks to data, and how life sciences will change as more people seek clinical trials as a form of alternative care. To discover more AI use cases, best practice guides, white papers, frameworks, and more, join Emerj Plus at emerj.com/p1.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in